(Q59600676)
Statements
A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group (English)
R Kälviäinen
M J Brodie
D Chadwick
D Edwards